script.reportAU
Sponsor

Sanofi-aventis Group

3 PBAC submissions on file, active 2005–2006. 67% have been recommended.

Submissions
3
2005 → 2006
Win rate
67 %
2 recommended of 3 bucketable
Drugs
2 · 2 listed
unique molecules submitted
PBS spend captured
FY-latest govt benefit on owned drugs

Drug portfolio

Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.

Therapy area mix

Oncology 2
Endocrinology 1

Activity by year

2005 (1) · 2006 (2)

Open on full dashboard →